Glasgow study reveals 'significant role' of genetics in Alzheimer's disease
A new study has revealed that genetics may play a more significant role in the development of Alzheimer's disease than previously thought.
The research, led by the University of Glasgow, published in the journal npj Dementia, found that while better memory, reasoning, and reaction times were linked to a lower risk of Alzheimer's disease up to 15 years later, this protective effect was significantly reduced in people with a higher genetic risk.
Researchers focused on the APOE e4 genotype, which is present in roughly one in four people and is the strongest known genetic predictor of late-onset Alzheimer's.
Read more: Glasgow drugs trial to use genetics to 'personalise' treatments
A single copy of the APOE e4 gene increases Alzheimer's risk threefold, while two copies raise the risk by twelvefold.
Dr Donald Lyall, senior lecturer in population brain health at the University of Glasgow's School of Health and Wellbeing, said: "Our study adds to the knowledge gap that exists on the relationship between genetic factors, cognitive health generally, and subsequent risk of dementia in later life.
"Our findings suggest that genetics plays a more significant role than previously thought and may influence the risk or protection conferred by other factors like premorbid cognitive health."
In the study, people with above-average reasoning ability were found to have a 36% lower risk of developing Alzheimer's within 15 years.
However, for those who also carried the APOE e4 gene, the risk reduction dropped to just 21%.
More strikingly, individuals with high reasoning skills but who carried the APOE e4 genotype were more likely to develop Alzheimer's than those with below-average reasoning but no genetic risk factor.
The researchers analysed data from over 252,000 UK Biobank participants aged 55 and older, with the average age at the start of the study being just over 62.
To ensure long-term accuracy, individuals diagnosed with Alzheimer's within two years of testing were excluded.
Researchers excluded individuals diagnosed with Alzheimer's within two years of cognitive testing.
The study reinforces the challenges in identifying effective therapies for Alzheimer's, particularly given the influence of genetic factors.
Read more: Public urged to shape health board's anti-racism strategy - how you can help
Dr Lyall said: "Our study has important implications regarding dementia; namely that genetics clearly plays a significant role in influencing someone's overall risk of Alzheimer's disease as they age."
The findings underscore the complex interplay between cognitive health and genetics and the challenges in developing therapies that can effectively prevent or treat Alzheimer's.
While cognitive resilience still matters, the research highlights the urgent need to understand genetic risk factors in the fight against one of the world's most devastating neurodegenerative conditions.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
an hour ago
- Business Upturn
Marksans Pharma's UK subsidiary secures approval for Oxybutynin Hydrochloride oral solution
By Aditya Bhagchandani Published on June 19, 2025, 09:14 IST Marksans Pharma Limited announced today that its wholly owned UK-based subsidiary, Relonchem Limited, has received Marketing Authorization for Oxybutynin Hydrochloride 2.5mg/5ml Oral Solution from the UK's Medicines & Healthcare Products Regulatory Agency (MHRA). The product, used primarily for treating overactive bladder and urinary incontinence, expands Marksans' offering in the urology therapeutic segment and strengthens its European portfolio. The company, headquartered in Mumbai, manufactures and markets generic pharmaceutical formulations globally, with facilities in India, the US, and the UK—approved by regulatory bodies including the USFDA, UKMHRA, and Australia's TGA. 'This approval further reinforces our commitment to expanding our presence in regulated markets through high-quality generic products,' the company said in a press release. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Yahoo
3 hours ago
- Yahoo
A Study Has Revealed The Biggest Risk Factors For Getting Early Dementia, And Knowledge Is Power
A recent study by the University of Exeter and Maastricht University published in JAMA Neurology has identified some of the factors that can lead to early cases of dementia ― some of which may surprise you. The data analyzed the behaviors of over 350,000 participants younger than 65 across the United Kingdom to evaluate young-onset dementia, which occurs before age 65. The researchers found there are 15 common issues that can contribute to the early development of the condition. A few have to do with genetics and other elements outside our control, but many others are modifiable. The study is meaningful to experts because it 'looks at young-onset dementia risk factors in a way that has only been done in late-onset dementias previously,' according to Dr. Kevin Bickart, an assistant professor in neurology at the University of California Los Angeles Health's David Geffen School of Medicine. The study features 'a very large sample that was prospectively followed from healthy baseline to a dementia diagnosis with lots of data collection.' Here's what to know: The biggest risk factors for young-onset dementia: Related: "This Has Taken Me Years And Years And YEARS To Figure Out": This Woman's Clever Way To Tell If Someone Is Your Real Friend Is Being Called The Most Accurate Thing Ever Related: 25 Eye-Opening Confessions From A Trauma Therapist That Changed The Way I Think About Mental Health The large-scale study looked at 39 possible risk factors and determined that 15 of them made the biggest difference when it came to developing dementia before the age of 65. Those include: Social isolation Lower formal education Lower socioeconomic status Carrying two copies of the APOE gene (a marker that influences Alzheimer's risk) Vitamin D deficiency Hearing impairment Alcohol use disorder No alcohol use (abstinence) Depression High C-reactive protein levels Lower handgrip strength (physical frailty) Orthostatic hypotension (a form of low blood pressure) Stroke Diabetes Heart disease Although some recognized risks are out of many people's control ― like being a carrier of the APOE gene or your socioeconomic status ― others can be managed through lifestyle changes. What you can do to lower your risk of early-onset dementia. Overall, the study results are consistent with what medical experts have been advising patients for years. Dr. Arman Fesharaki-Zadeh, an assistant professor of psychiatry and of neurology at the Yale School of Medicine, recommended three 'lifestyle measures' that folks may want to consider when trying to lower their risk of young-onset dementia ― starting with physical exercise. 'An active daily exercise practice can have far-reaching benefits, which include enhanced neurocognitive function,' Fesharaki-Zadeh said, adding that physical activity can boost neurogenesis (the formation of new neurons and synapses), vasculogenesis (the creation of new blood vessels) while also providing inherent mood benefits. Next, focus on eating nourishing foods. Fesharaki-Zadeh championed a Mediterranean-based diet, mentioning its well-documented benefits. 'Such dietary practice, which includes food groups such as green leafy vegetables, olive oil, salmon and blueberries, is rich in vitamins, omega-3 fatty acids, as well as antioxidants ― all neuroprotective factors,' he explained. Fesharaki-Zadeh recommended cognitive, mood and social stimulation to keep your mind sharp. For cognitive stimulation, this could look like learning a new language or attending a seminar, listening to music or dancing. Basically, anything that engages your mind will help it stay healthy. Mood stimulation, on the other hand, relates to stress reduction practices, 'such as mindfulness and yoga,' Fesharaki-Zadeh said. As for social stimulation, it's pretty simple: Try to connect with other humans face-to-face and actually talk to them as much as possible. 'In the era of pandemic and now post-pandemic, quality social connections should increasingly be encouraged and practiced,' Fesharaki-Zadeh said. While these habits don't cover the whole list of dementia risk factors, they are a pretty solid article originally appeared on HuffPost. Also in Goodful: Therapists Are Revealing The Moments That Made Them Break Their "No Judgment" Rule, And I'm Honestly Speechless Also in Goodful: 19 "Garbage" Modern Trends People Refuse To Partake In Despite Their Popularity Also in Goodful: Medical Professionals Are Sharing "Mundane" Things That Actually Make So Many People Sick
Yahoo
5 hours ago
- Yahoo
Scarlett Johansson, Jonathan Bailey and ‘Jurassic World Rebirth' Cast Stun London at World Premiere
London took cover from some signature Jurassic World dinos Tuesday night as the cast of Gareth Edwards' Rebirth ushered in a brand new installment. The movie's leads Scarlett Johansson, Mahershala Ali, Jonathan Bailey and Rupert Friend, as well as the director and film producers were in attendance at the glitzy world premiere taking place at the Odeon Luxe in Leicester Square. More from The Hollywood Reporter Eurovision Drama and 'The Nameless': Movistar Plus+ Exec Touts Focus on Event Programming Lewis Hamilton Signed Off on Brad Pitt and Damson Idris' Driving in 'F1: The Movie' In Spain, Warner Exec Explains the HBO Max Rebrand Screaming fans flanked the green carpet hoping to catch a glimpse of the talent taking on a brand new Jurassic challenge. Johansson donned a form-fitting pink dress while co-star Bailey kept it casual and reminiscent of the '90s — when Jurassic Park first released — in a cap and blazer. 'You make a film like this and directors get all the credit,' Edwards told the audience ahead of the screening. 'It just isn't fair,' he said, before introducing the lead cast as well as ensemble players Manuel Garcia-Rulfo, Luna Blaise, David Iacono, Audrina Miranda, Philippine Velge, Bechir Sylvain and Ed Skrein. 'Just like the dinosaurs in these films, you sort of hold on as long as you can,' the Rogue One director continued about his latest feature. 'And you try to contain it… but at some point it escapes and it's out in the world. [The dinosaurs] all belong to you now.' If tracking is correct, the Universal movie — the seventh in a franchise that began with Steven Spielberg's 1993 smash hit — should open anywhere from $120 million to $125 million over the five-day holiday corridor, The Hollywood Reporter reported last week. Jurassic World Rebirth, penned by David Koepp, takes place five years after the events of filmmaker Colin Trevorrow's Dominion. Earth's environment now proves inhospitable to dinosaurs and other de-extinct animals, and the ones who survive now reside in remote, tropical locales. Zora Bennett, a covert operative played by Johansson, is recruited by a pharmaceutical company to band together with paleontologist Dr. Henry Loomis (Bailey) and team leader Duncan Kincaid (Ali) on a top-secret mission. Jurassic World Rebirth opens in North America and in the U.K. on July 2. Best of The Hollywood Reporter 13 of Tom Cruise's Most Jaw-Dropping Stunts Hollywood Stars Who Are One Award Away From an EGOT 'The Goonies' Cast, Then and Now
